ONCOTELIC TO PARTICIPATE AT THE ASCO 2024 MEETING : vimarsan

AGOURA HILLS, Calif., May 20, 2024 -- Oncotelic Therapeutics, Inc announced today its Chief Clinical Officer- Dr. Anthony Maida will be participating at the ASCO 2024 meeting. Abstract: e16318....

Related Keywords

Anthony Maida , Mateon Therapeutics Inc , Pointr Data Inc , Globenewswire Inc , Oxigene Inc , Company Annual Report On Form , Oncotelic Therapeutics Inc , Chief Clinical , New York , Diffuse Intrinsic Pontine Glioma , Acute Myeloid Leukemia , Parkinson Disease , Annual Report , Cautionary Note , Private Securities Litigation Reform Act ,